XM does not provide services to residents of the United States of America.
A
A

ASMLHolding

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Bureau Veritas, Covestro AG, Redcare Pharmacy NV

EUROPE RESEARCH ROUNDUP-Bureau Veritas, Covestro AG, Redcare Pharmacy NV Oct 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bureau Veritas, Covestro AG and Redcare Pharmacy NV, on Wednesday. HIGHLIGHTS * British Land BLND.L : Deutsche Bank raises to buy from hold * Bureau Veritas BVI.PA : JP Morgan cuts to neutral from overweight * Covestro AG 1COV.DE : Jefferies cuts to hold from buy * Redcare Pharmacy NV RDC.DE : HSBC raises t
A
A
A
B
B
B
D
E
E
E
E
E
E
E
F
G
I
M
M
A
A
A
A
B
B
E
G
Z

Europe before the bell: futures steady, M&A on the radar

LIVE MARKETS-Europe before the bell: futures steady, M&A on the radar Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE BEFORE THE BELL: FUTURES STEADY, M&A ON THE RADAR European shares look set to steady on Tuesday following a negative finish to the third quarter on Monday, when warnings from Stellantis STLAM.MI , VW VOWG_p.DE and Aston Martin AML.L raised fresh concern ove
P
V
A
E
F
U
G

China, South Korea, Taiwan to spend most on chip equipment 2025-2027, industry body says

China, South Korea, Taiwan to spend most on chip equipment 2025-2027, industry body says AMSTERDAM, Sept 26 (Reuters) - Semiconductor manufacturers will spend a record $400 billion on computer chip-making equipment in 2025-2027, global industry association SEMI said in estimates published on Thursday, with China, South Korea and Taiwan leading the way.
A
K
L

U.S. STOCKS ASML Holding, Meta, Crocs

BUZZ-U.S. STOCKS ON THE MOVE-ASML Holding, Meta, Crocs Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set to open higher on Thursday as Micron's upbeat forecast revived the frenzy around artificial intelligence, while investors assessed a labor market report and awaited comments from Federal Reserve Chair Jerome Powell.
C
M
M
N
Q
S
A
U
E
R
C

U.S. STOCKS Accenture, Starbucks, Southwest Airlines

BUZZ-U.S. STOCKS ON THE MOVE-Accenture, Starbucks, Southwest Airlines Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures climbed on Thursday after Micron's upbeat forecast revived the euphoria around artificial intelligence on Wall Street, while investors also awaited economic data and remarks from Federal Reserve Chair Jerome Powell.
A
C
M
M
N
Q
S
A
U
E
T
C

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.